Innate immune proteins as biomarkers for CNS injury: critical evaluation (WO2013119673 A1)

Bibliography

• Walsh JG, Muruve DA, Power C. Inflammasomes in the CNS. Nat Rev Neurosci 2014;15(2):84-97
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Janeway CJr. Innate immunity. N Engl J Med 2000;343(5):338-44
   PubMed Web of Science ®Google Scholar
• Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009;22(2):240-73
   PubMed Web of Science ®Google Scholar
• Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007;27(4):549-59
   PubMed Web of Science ®Google Scholar
• Kim EH, Won JH, Hwang I, et al. Cobalt chloride-induced hypoxia ameliorates NLRP3-mediated caspase-1 activation in mixed glial cultures. Immune Netw 2013;13(4):141-7
   Google Scholar
• Choi AJ, Ryter SW. Inflammasomes: molecular regulation and implications for metabolic and cognitive diseases. Mol Cells 2014;37(6):441-8
   PubMed Web of Science ®Google Scholar
• Mariathasan S, Newton K, Monack DM, et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004;430(6996):213-18
   PubMed Web of Science ®Google Scholar
• Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002;10(2):417-26
   PubMed Web of Science ®Google Scholar
• Schroder K, Tschopp J. The inflammasomes. Cell 2010;140(6):821-32
   PubMed Web of Science ®Google Scholar
• de Rivero Vaccari JP, Lotocki G, Marcillo AE, et al. A molecular platform in neurons regulates inflammation after spinal cord injury. J Neurosci 2008;28(13):3404-14
   Google Scholar
• de Rivero Vaccari JP, Lotocki G, Alonso OF, et al. Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury. J Cereb Blood Flow Metab 2009;29(7):1251-61
   Google Scholar
• Bianchi ME. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007;81(1):1-5
   PubMed Web of Science ®Google Scholar
• Wakefield D, Gray P, Chang J, et al. The role of PAMPs and DAMPs in the pathogenesis of acute and recurrent anterior uveitis. Br J Ophthalmol 2010;94(3):271-4
   Google Scholar
• Hernangomez M, Carrillo-Salinas FJ, Mecha M, et al. Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating Cd200-Cd200r interaction involve the cannabinoid system. Curr Pharm Des 2014;20(29):4707-22
   Google Scholar
• Shastri A, Bonifati DM, Kishore U. Innate immunity and neuroinflammation. Mediators Inflamm 2013;2013:342931
   Google Scholar
• Ransohoff RM, Brown MA. Innate immunity in the central nervous system. J Clin Invest 2012;122(4):1164-71
   PubMed Web of Science ®Google Scholar
• Downes CE, Crack PJ. Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS? Br J Pharmacol 2010;160(8):1872-88
   Google Scholar
• Risdall JE, Menon DK. Traumatic brain injury. Philos Trans R Soc Lond B Biol Sci 2011;366(1562):241-50
   Google Scholar
• Gordon WA, Brown M, Sliwinski M, et al. The enigma of hidden traumatic brain injury. J Head Trauma Rehabil 1998;13(6):39-56
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69(3):89-95
   PubMed Web of Science ®Google Scholar
• Shen S, Loo RR, Wanner IB, et al. Addressing the needs of traumatic brain injury with clinical proteomics. Clin Proteomics 2014;11(1):11
   PubMedGoogle Scholar
• Keane RW, Dietrich WD, de Rivero Vaccari JP, et al. Innate immune proteins as biomarkers for CNS injury. WO2013119673 A1; 2013
   Google Scholar
• Crary J, Mckee A. Biomarkers for chronic traumatic encephalopathy. WO2014100663 A2; 2014
   Google Scholar
• Wang KK, Hayes R, Liu MC, et al. Proteolytic biomarkers for traumatic injury to the nervous system. US7456027 B2; 2008
   Google Scholar
• Adamczak S, Dale G, de Rivero Vaccari JP, et al. Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article. J Neurosurg 2012;117(6):1119-25
   Google Scholar
• Juengst SB, Kumar RG, Failla MD, et al. Acute inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury. J Head Trauma Rehabil 2014. [Epub ahead of print]
   Google Scholar
• Hall RJ, Ferguson KJ, Andrews M, et al. Delirium and cerebrospinal fluid S100B in hip fracture patients: a preliminary study. Am J Geriatr Psychiatry 2013;21(12):1239-43
   Google Scholar
• Kumar RG, Boles JA, Wagner AK. Chronic inflammation after severe traumatic brain injury: characterization and associations with outcome at 6 and 12 months postinjury. J Head Trauma Rehabil 2014. [Epub ahead of print]
   Google Scholar
• Zhang Z, Zoltewicz JS, Mondello S, et al. Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products. PLoS One 2014;9(3):e92698
   PubMed Web of Science ®Google Scholar
• Zurek J, Fedora M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir (Wien) 2012;154(1):93-103
   Google Scholar
• Mondello S, Muller U, Jeromin A, et al. Blood-based diagnostics of traumatic brain injuries. Expert Rev Mol Diagn 2011;11(1):65-78
   PubMed Web of Science ®Google Scholar
• Posti J, Hyötyläinen T, Jäntti S, et al. Depuy-synthes award for resident research on brain and craniofacial injury 155 blood metabolic patterns correlate with the severity of traumatic brain injury. Neurosurgery 2014;61:211
   Google Scholar